From the day she was born, Olivia Eberts has been a fighter. Born 115 days before her due date, at 23 weeks and 4 days, she has persevered through a heart surgery and multiple health problems.
“She’s a miracle because she wasn’t expected to survive,” said her mother, Jamie-Lee Eberts. “It’s going to be a lifelong battle for her, and we don’t know what the future may bring.”
Unfortunately, some of the breathing equipment that helped keep Olivia alive has damaged her developing lungs, causing a chronic condition called Bronchopulmonary dysplasia (BPD). She is one of the 1,000 babies born prematurely in Canada every year who will be diagnosed with BPD. This condition harms the brain and stunts growth, and complications can lead to blindness or cerebral palsy. There is no cure.
Dr. Bernard Thébaud wants to change that. The neonatologist and senior scientist at The Ottawa Hospital and CHEO is working on a therapy for BPD based on umbilical cord stem cells.
“What we see in the lab is very promising,” said Dr. Thébaud. “We think stem cells are going to be a game-changer for these babies.”
Dr. Thébaud’s team discovered that stem cells from umbilical cords could prevent and even repair lung damage in animal models of BPD. The cells act like mini pharmacies, diagnosing the problem at hand and dispensing the appropriate healing factors. Now his goal is to bring this discovery to the sick babies he sees every day through a clinical trial, which he hopes to launch in the near future. His team recently received a grant from the Ontario Institute for Regenerative Medicine that will help them do the necessary research to prepare for just such a trial.
“I am confident that we have the talent and the tools here to find a treatment for BPD,” said Dr. Thébaud. “I moved to Ottawa specifically to drive stem cell treatments to the clinic. Step by step, our findings are helping us get there.”
Extremely premature babies require complex care, life support, and round-the-clock monitoring until they reach full-term (39 to 40 weeks). As well as investing in research, The Ottawa Hospital is building a new Neonatal Intensive Care Unit to provide all private rooms, the new standard for delivering care to pre-term babies, to allow for room for staff and parents, critical equipment, and quiet – which is essential for development.
We thank you for believing how critical neonatal research and the building of a new Neonatal Intensive Care Unit is for babies like Olivia to receive the best, most up-to-date treatments developed at The Ottawa Hospital. You are helping give prematurely born babies the best chance at surviving, thriving and growing up.
To learn more about Dr. Thébaud’s work, click here.